GLP-1 Appeal Levels Explained: What Each Denial Stage Means (2026)
By The RX Index Editorial Team — a pricing intelligence and comparison resource for GLP-1 telehealth providers. This page is general information — not medical, legal, or insurance advice. Your denial letter and plan documents set your real deadlines.
When your insurance says no to Wegovy, Zepbound, Ozempic, or Mounjaro, you usually move through a set order of steps. On most private and Marketplace (ACA) plans that’s an internal appeal first, then an outside external review. Medicare drug plans have five levels. Medicaid follows your state’s process. But here’s the thing almost no one tells you up front: the level matters less than one line on your denial letter — the reason they gave.
Most people lose time at the wrong door. They start writing a long, emotional appeal before they’ve read why they were denied — and too often, the denial was something a single missing document would have fixed. So before you spend a week on this, do two things: read the reason on your letter, then find your spot on the map below.
GLP-1 Appeal Levels Explained: Where You Are, and What’s Next
Find your insurance type in the left column. You’ll see what each stage means, how long you have, and the one catch that trips people up. We pulled the official rules into one place — normally you’d need five or six government pages to see all of this.
| Your insurance | Level 1 usually is… | Level 2 usually is… | Higher levels | How long you have / how fast they decide | The catch |
|---|---|---|---|---|---|
| Private or Marketplace (ACA) plan | Internal appeal — you ask the insurer to look again | External review — an independent outside reviewer decides, and the plan must follow it | State or federal review depending on the plan | Internal appeal: file within 180 days. Decision: 30 days (care not yet received), 60 days (care already received), or 72 hours expedited. External review: request within 4 months; standard decision within 45 days. | “ACA plan” includes plans bought directly through Healthcare.gov and state exchanges — most employer plans run on different rules |
| Employer plan (ERISA) | Internal appeal under the plan’s rules | A second internal appeal or external review, depending on the plan | Possible court review after you finish the plan’s appeals | At least 180 days to ask for review; decisions range from 72 hours (urgent) to about 60 days by claim type | If your employer “self-funds” the plan, your state insurance office may not handle it — the plan’s own rules and the federal process apply |
| Medicare Part D (drug plan) | Redetermination — the plan reviews its own denial | Reconsideration by an Independent Review Entity (an outside reviewer hired by Medicare) | ALJ hearing → Medicare Appeals Council → federal court | File within 65 days of the date on your notice (changed from 60 in 2025 — go by your letter). Standard drug decision in 7 days, fast appeal in 72 hours. | Medicare can’t cover a GLP-1 for weight loss alone, but the $50 Medicare GLP-1 Bridge opens July 1, 2026 — and other uses (diabetes, heart risk, sleep apnea) may be covered |
| Medicaid / Medicaid managed care | A plan appeal and/or a state fair hearing, depending on your state and plan | A state hearing or extra state-specific review | State-specific | Varies by state — your denial notice sets the deadline. Look for a “continuation of benefits” deadline separately. | Don’t use a private-insurance timeline. Your notice is the only deadline that counts. |
| State external review (e.g., Pennsylvania) | You usually must finish the internal appeal first | Independent external review by an assigned organization | Binding decision under state law | Request within 4 months; standard decision within 45 days, urgent within 72 hours | Every state runs this a little differently — use the state on your denial notice |
Get your personalized next step — free →
Not sure whether to appeal, switch tactics, or look at another option? Free 60-second GLP-1 matching quiz. No account. About a minute.
No time for the quiz? Quick rule:
- First denial: Level 1 / internal appeal (or redetermination on Medicare).
- Final internal denial: external review (or Independent Review Entity on Medicare).
- Medicaid denial: read your notice first — the path and deadline are set by your state.
What we verified for this section:
Appeal timelines from HealthCare.gov and the U.S. Department of Labor. Medicare’s five levels and the 2025 deadline change from Medicare.gov and CMS. Medicaid appeal rights from KFF. Pennsylvania external-review timeline from the Pennsylvania Insurance Department. Bridge program details from CMS.
What Does “GLP-1 Appeal Levels” Actually Mean?
GLP-1 appeal levels are the stages you go through after an insurer denies your medication, your prior authorization, your refill, or your renewal. For most private plans the order is internal appeal, then external review. Medicare drug plans use a five-level process, and Medicaid depends on your state. Each level simply decides who looks at your case next.
Let’s clear up the words you’ll see on your letter, because the jargon is half the stress.
- Prior authorization (PA)
- Your plan's permission slip — the form your doctor sends asking the plan to approve a drug before the pharmacy can fill it. A denied prior authorization is the most common GLP-1 denial, and it's often fixable.
- Internal appeal
- You're asking the same insurance company to review its own decision again — but a different person has to make the call this time.
- External review
- The fight leaves the insurance company. An independent outside group (sometimes called an Independent Review Organization, or IRO) looks at your case. For most private plans, their decision is binding — the insurer has to honor it.
- Redetermination / reconsideration
- Medicare's names for its first two appeal levels. Redetermination = the plan reviews its own denial. Reconsideration = an outside reviewer checks the plan's decision.
The simple version of the ladder:
- Level 0: the denial itself — a rejected PA, a pharmacy “not covered,” or a coverage decision. Comes before a formal appeal.
- Level 1: internal appeal (private/employer) or redetermination (Medicare). You fill gaps and challenge the reasoning.
- Level 2: external review (private plans) or Independent Review Entity (Medicare).
- Higher levels: Medicare hearings, state Medicaid hearings, or court — used in tougher, rarer cases.
Why GLP-1 denials feel more confusing than other denials
GLP-1 coverage is a moving target right now. The denial can come from a lot of directions at once:
- Prior authorization rules that change often
- Plans that exclude weight-loss drugs entirely
- A mix-up between a diabetes use and an obesity use
- Step therapy — being told to try a cheaper drug first
- Continuation rules when you renew
- A drug that’s not on the plan’s preferred list
- Your employer changing the benefit
- Medicare and Medicaid limits
The map above tells you which building you’re in. The next section tells you which door is worth knocking on.
Which Appeal Level Are You on Right Now?
If this is your first no after a prior authorization, you’re usually at Level 1 — the internal appeal or redetermination. If you already lost that, you may be eligible for external review (private plans), an Independent Review Entity (Medicare), a state fair hearing (Medicaid), or another escalation step. Your insurance type decides which. Here’s how to place yourself fast.
A private or Marketplace plan denied your first request
You're at the internal appeal stage. You have 180 days to file, and the plan must decide standard requests within 30 days (care not yet received) or 60 days (care already received), per HealthCare.gov.
Your internal appeal was already denied
Now you can ask for an external review — the independent outside look. Standard external reviews are decided in 45 days or less, and urgent ones in 72 hours, per HealthCare.gov. For most plans, that decision is final and binding on the insurer.
Your employer plan denied you
Employer plans run on federal rules. You generally get at least 180 days to ask for review, and the U.S. Department of Labor says the person who reviews your appeal can't be the same person who denied you the first time.
A Medicare drug plan denied you
You're starting the five-level Medicare process at redetermination. Each denial letter tells you how to move to the next level. We break all five down further below.
Medicaid denied you
Your path depends on your state and whether you're in Medicaid managed care. Some people appeal to the plan first; others go straight to a state fair hearing. Use the deadline on your notice — not a generic one you read online.
Still deciding if it’s worth it? →
Run your situation through our free 60-second GLP-1 matching quiz before you spend another week on the wrong move. It’ll flag your likely next step and the options around it. No pressure, no account.
Is Your GLP-1 Denial Actually Worth Fighting?
Most GLP-1 denials can be appealed — but they’re not all equally winnable. Missing-paperwork, “not medically necessary,” step-therapy, and renewal denials usually give you a real shot. A true “weight-loss drugs are excluded” denial is the hardest, because an appeal can’t add a benefit your plan doesn’t sell. Match the words on your letter before you spend a week appealing the wrong thing.
The most useful idea on this page, said plainly:
Appealable is not the same as winnable. You can almost always ask for a review. Whether you’ll win depends on the reason. Read your denial letter, find the reason, and use the fixability chart below.
| What your letter says | What it usually means | How fixable | What to do next | Best proof to attach |
|---|---|---|---|---|
| “Missing information” / “records not received” | The plan didn’t get enough notes, BMI history, diagnosis codes, or treatment history | High | Resend a complete request or file a Level 1 appeal with the missing pieces — sometimes this isn’t even an “appeal,” just a fix | Denial letter, chart notes, BMI/weight history, diagnosis, medication history |
| “Not medically necessary” | The plan says you don’t meet its rules | Medium–High | Appeal by matching the plan’s exact rules, line by line | Doctor’s letter of medical necessity, your other health conditions, past attempts, labs |
| “Step therapy required” | The plan wants you to try a cheaper drug first (often phentermine) | Medium | Ask for a step-therapy exception if you already tried it, can’t take it, or it’s not safe for you | Dates, doses, side effects, or why the cheaper drug is wrong for you |
| “Non-formulary” | The drug isn’t on the plan’s preferred list | Medium | Ask for a formulary exception, or ask which covered drug they’d approve | Why the preferred options don’t fit you |
| “Continuation criteria not met” | At renewal, the plan wants proof it’s working | Medium–High | Appeal with your starting numbers and your current results | Starting weight/BMI, current results, that you’re taking it as prescribed |
| “Weight-loss drugs excluded” | Your plan simply doesn’t cover obesity meds as a benefit | Low | Check if a different covered use applies, ask your employer about an exception, or compare cash-pay — don’t burn weeks on a low-odds appeal | Denial letter, plan document, documents for any other approved use |
| “Diagnosis not covered” | The diagnosis code or use doesn’t match the plan’s rules | Medium | Ask your doctor to double-check the diagnosis code and the approved use | Correct diagnosis, the FDA-approved use, clinical notes |
Here’s the honest part
A GLP-1 appeal is not magic. If your plan flatly excludes weight-loss medications, a standard Level 1 appeal usually won’t force them to cover obesity treatment. You can’t appeal your way into a benefit the plan doesn’t offer. But a true exclusion is the only common denial that’s genuinely low-odds. Everything else on that chart is fightable. And even with an exclusion, you usually still have moves: a different covered use (heart risk, sleep apnea, diabetes, or liver disease), an employer exception, or a transparent cash-pay path that’s faster than appealing.
See whether to appeal or pivot →
If you’re staring at your letter unsure what to do, our free 60-second quiz points you toward the smartest next step — appeal, a different covered use, or a cash-pay path. No pressure, no account.
How Often Do GLP-1 Appeals Actually Work?
Appeals are badly underused — fewer than 1% of denied Marketplace claims are ever appealed. When people do appeal, insurers reverse a meaningful share, and outside reviewers overturn denials often enough that the step is worth considering. The biggest predictor of winning isn’t luck — it’s filing on time with the right documents.
Insurers on HealthCare.gov denied about 1 in 5 in-network claims (19%) in 2024 — yet fewer than 1% of denied claims were appealed (roughly 1 in 300). Of the people who did appeal internally, KFF found insurers upheld the denial in 66% of cases — which means about 34% were reversed. That’s roughly one in three denials flipping, for people willing to send one good appeal.
| Source (year) | Plan type | What was appealed | How often people appealed | How often overturned | Does it apply to your GLP-1? |
|---|---|---|---|---|---|
| KFF (2024) | Marketplace / ACA | Denied claims (medical + Rx) | Fewer than 1% | ~34% reversed on internal appeal | Closest to a commercial GLP-1 denial — your odds depend on the reason |
| KFF (2024) | Medicare Advantage | Prior-authorization denials (all services) | ~11.5% | ~80% overturned | Not GLP-1-specific — shows denials are often reversed when challenged |
| Health Affairs (2025) | Several states | External-review decisions | — | Close to half overturned | Not GLP-1-specific — shows the outside-review step has real teeth |
The takeaway isn’t a promise. It’s that the first no is not the final answer nearly as often as people assume. Most people who get denied just stop. The system quietly counts on that. The flip side is the deadline — a late appeal can fail before anyone reads your evidence.
What Happens at Level 1 (the Internal Appeal)?
Level 1 is the internal appeal or redetermination, where the insurer or plan reviews the denial again. This is where you fill the gaps, answer the plan’s exact reasons, and send the documents the denial letter asked for. It’s also where most winnable denials get reversed.
What the plan is actually reviewing
- •Its coverage rules for your drug
- •Whether you meet "medical necessity"
- •Your diagnosis and approved use
- •What you've tried before
- •Step-therapy requirements
- •Whether the drug is on the formulary
- •Renewal/continuation results, if it's a refill denial
What to send at Level 1 (the core packet)
- •Your denial letter
- •The plan's coverage rule or policy
- •The prescription details
- •Your diagnosis and code
- •BMI and weight history, when relevant
- •Other health conditions (blood pressure, prediabetes, sleep apnea, heart disease)
- •Past treatments you tried, with dates
- •A letter of medical necessity from your prescriber
- •Pharmacy records
- •Your current results, if this is a renewal
“Not medically necessary”? Answer it like this:
This is the most common denial worth fighting. The structure that works:
- Quote the exact reason they gave.
- Quote or summarize the plan’s rule.
- Show where your medical record meets that rule.
- Attach the record that proves it.
- Ask for a reversal — or the specific exception you need.
Don’t send a 30-page packet of general studies. Send the few pages that answer their reason. Skip the emotional speech; lead with the facts that match the rule.
Resubmit or appeal? (They’re not the same.)
- Resubmit if the denial was clearly a paperwork or coding gap.
- Appeal if the plan actually reviewed your request and said no on the rules.
- When in doubt, call the number on your card and ask which path protects your deadline.
Either may be allowed depending on your plan, but GLP-1 appeals usually turn on diagnosis and medical necessity, so your prescriber’s input is key. You can also name an authorized representative to file an external review for you, per HealthCare.gov.
Check your GLP-1 coverage before you appeal (advertiser)
Best fit if you have commercial insurance and want to know what your plan covers before you spend time appealing. Ro’s free GLP-1 Insurance Coverage Checker contacts your insurer and sends you a plain-English report: whether Ozempic, Wegovy, and Zepbound look covered, whether prior authorization is required, your likely copay, and what options exist if you’re not covered. New Ro accounts also get a $50 credit. It won’t win an appeal for you or judge your denial letter — but it shows what Ro was able to verify with your plan, so you’re not working blind.
Check my GLP-1 coverage with Ro — free →The RX Index may earn a commission if you start care through this link, at no extra cost to you.
What if Your Denial Says “Step Therapy” or “Non-Formulary”?
Step therapy means the plan wants you to try another medication first. Non-formulary means your drug isn’t on the plan’s preferred list. These are usually exception problems, not automatic dead ends — but you have to ask for the right exception and attach the right proof.
Step therapy (“try the cheaper drug first”)
Plans often require a less expensive option — frequently phentermine — before they’ll cover a GLP-1. You can ask for a step-therapy exception if any of these are true: you already tried the required drug and it didn’t work, you can’t take it safely, or it’s medically wrong for you. The proof that wins: the name of the drug you tried, the dates and dose, what happened (side effects or no result), and a clear note from your prescriber on why repeating it isn’t appropriate.
Non-formulary or a mid-treatment switch
If your drug isn’t on the preferred list, ask for a formulary exception or ask which GLP-1 the plan would cover. This also covers a situation a lot of people hit: a plan moving patients off one drug and onto another. If the specific medication matters for you clinically — for example, you’ve been stable and responding on your current GLP-1 — document that response and have your prescriber explain why switching is a real clinical concern, not just a preference.
Not sure which exception your letter calls for? →
Our free 60-second quiz reads your denial reason and points you to the right next move — step-therapy exception, formulary exception, a covered alternative, or a cash-pay path. No account.
What Happens at Level 2 (External Review)?
Level 2 is the escalation after the first appeal fails. For most private plans that means external review by an independent reviewer whose decision binds the insurer. For Medicare Part D, it’s reconsideration by an Independent Review Entity. This is your shot at a fresh set of eyes outside the company that denied you.
Private plans: external review
Once the internal appeal is a final no (a “final adverse benefit determination”), you can request an external review. An independent organization weighs your plan’s terms, the medical evidence, and the denial reason. Standard external reviews are decided in 45 days or less, and the decision is binding on the insurer, per HealthCare.gov. If your case is urgent, you can sometimes request external review at the same time as the internal appeal.
Medicare: the Independent Review Entity
- Level 1: the plan’s redetermination
- Level 2: reconsideration by an Independent Review Entity (an outside reviewer hired by Medicare)
- Standard drug appeals decided in about 7 days; fast appeals in 72 hours when waiting could seriously harm your health, per Medicare.gov
What to add at Level 2 that you didn’t have at Level 1:
- The Level 1 denial letter
- Your original packet
- A point-by-point answer to each reason they gave
- The plan’s policy language
- Your letter of medical necessity
- Any new evidence
- A doctor’s urgency note if you’re asking for a fast decision
Heading to external review? →
Use the document checklist above to build your escalation packet, and beat your deadline. Want a sanity check on your next move first? Take the free 60-second quiz.
How Do Medicare GLP-1 Appeals Work?
Medicare drug appeals have five levels, and each denial letter tells you how to move to the next one. But the bigger issue for GLP-1s is what Medicare can cover. Medicare can’t pay for a GLP-1 used only for weight loss — though it can cover one for a different approved use, and a new 2026 program opens a weight-loss path at $50 a month.
The five Medicare levels, in plain English
| Level | What it means | What you do |
|---|---|---|
| Level 1 | Plan redetermination | Ask your drug plan to review its denial |
| Level 2 | Independent Review Entity reconsideration | Ask an outside reviewer to check the plan’s decision |
| Level 3 | ALJ hearing (a Medicare judge) | Escalate if your case meets a dollar minimum ($200 in 2026) |
| Level 4 | Medicare Appeals Council | Review of the Level 3 decision |
| Level 5 | Federal court | Final step if the dollar minimum is met ($1,960 in 2026) |
A deadline warning worth circling
The window to file a Part C/D appeal changed from 60 to 65 calendar days, effective January 1, 2025, per CMS. Some older pages still say 60. The only deadline that counts is the one printed on your denial letter — read it and mark your calendar the day it arrives, because the clock starts from the letter’s date, not the day you opened it.
Why most Medicare weight-loss appeals fail (and what works instead)
By law, Medicare Part D can’t cover a drug used only for weight loss, as KFF explains. So appealing a weight-loss denial usually goes nowhere. The two paths that actually work:
1. A different covered use.
Medicare can cover a GLP-1 for certain FDA-approved, medically accepted uses: Ozempic or Mounjaro for type 2 diabetes, Wegovy to lower the risk of heart attack and stroke in adults with cardiovascular disease and overweight or obesity, Zepbound for moderate-to-severe obstructive sleep apnea in adults with obesity, and Wegovy for noncirrhotic MASH (a serious liver disease with moderate-to-advanced scarring). If one of these truly fits you, have your doctor submit for that use. Coverage still depends on your plan’s formulary.
2. The Medicare GLP-1 Bridge program ($50/month).
Starting July 1, 2026 through December 31, 2027, eligible Part D members can get Foundayo, Wegovy (injection or tablet), or the Zepbound KwikPen at a flat $50 monthly copay — and that copay doesn’t rise as your dose goes up. The Zepbound single-dose vial and single-dose pen are not included — only the KwikPen.
The program runs outside your normal Part D plan. Your doctor submits to a central processor (Humana), not to your plan — and requests won’t be accepted before July 1, 2026.
Bridge eligibility (per CMS — you must be in a Part D plan and be 18+, and fall into one of these three groups):
- BMI 35 or higher (on its own)
- BMI 30 or higher with heart failure with preserved ejection fraction, uncontrolled high blood pressure, or CKD stage 3a+
- BMI 27 or higher with prediabetes, a prior heart attack, a prior stroke, or symptomatic peripheral artery disease
Eligibility is based on your BMI when you started treatment — so if the medication worked and your BMI dropped, you can still qualify. The $50 doesn’t count toward your Part D deductible or $2,100 annual out-of-pocket cap (2026), and low-income subsidies don’t apply to it.
Medicare denial? Start with your letter’s deadline.
Organize your next step, then call your plan or your State Health Insurance Assistance Program (SHIP) — Medicare says SHIP can help you file appeals at no cost. For a weight-loss-only denial, the Bridge program or a covered-use submission usually beats appealing.
How Do Medicaid GLP-1 Appeals Work?
Medicaid GLP-1 appeals depend on your state, your plan, and whether you’re in Medicaid managed care. Your denial notice sets the deadline, so don’t borrow a private-insurance timeline. Coverage for obesity is also optional for states, which is why two people in different states can get opposite answers.
- Some people appeal to their managed-care plan first.
- Some go to a state fair hearing (a hearing run by the state).
- Some states add an outside medical review.
- Deadlines and steps vary — a lot.
Why Medicaid GLP-1 coverage keeps changing
As of January 2026, only 13 state Medicaid programs covered GLP-1s for obesity under regular (fee-for-service) Medicaid, usually with strict prior-authorization rules, per KFF. Coverage for diabetes and the heart-risk use is more common. So the same denial can be a hard “not covered here” in one state and a fixable paperwork issue in another.
What to pull off your Medicaid notice:
- Your appeal deadline
- Whether you appeal to the plan first
- The state fair-hearing deadline
- Whether you can keep the medicine during the appeal
- Whether a doctor's statement is required
- Where to send your records
- Whether a fast (expedited) review is available
Medicaid denial? Don’t guess your deadline. →
Confirm the exact filing steps on your notice, then take our free 60-second quiz to map your documents and options.
What Documents Make a GLP-1 Appeal Stronger?
A strong GLP-1 appeal doesn’t argue that GLP-1s work in general. It proves that this patient, with this diagnosis, meets this plan’s rule for this drug. Specific beats heartfelt every time.
The core document packet
- •Denial letter
- •Insurance card
- •Plan coverage policy
- •Prescriber appeal or letter of medical necessity
- •Diagnosis and code
- •BMI/weight history (when relevant)
- •Documentation of other health conditions
- •Past attempts and dates
- •Past drugs that failed or caused side effects
- •Relevant labs
- •Pharmacy records
- •Your current results (for a renewal)
Tailor it to the reason
When Should You Ask for a Fast (Expedited) Appeal?
A fast appeal is for real medical urgency — not normal frustration with delays. If waiting for the standard timeline could seriously harm your health, ask your prescriber whether an expedited appeal fits and whether they can document why. When it qualifies, decisions come in about 72 hours.
- Private plans: in urgent situations you may be able to request external review before the internal process finishes, and timelines shorten when urgency requires it, per HealthCare.gov.
- Medicare: a fast Part D appeal can give you a 72-hour decision when waiting could seriously harm your health and your plan or doctor agrees it qualifies, per Medicare.gov.
- State example (Pennsylvania): allows expedited external review when a delay could seriously jeopardize your life, health, or ability to regain function, with a decision generally within 72 hours.
What a fast appeal is not:
It’s not a shortcut because the drug is pricey, it’s not guaranteed, and it usually needs your clinician to back the urgency. Your denial letter or plan should explain how to request it.
What if Your Plan Flat-Out Excludes Weight-Loss GLP-1s?
A benefit exclusion is different from a denied prior authorization. If your plan simply doesn’t cover obesity meds, the smarter moves are checking for a different covered use, asking your employer or plan about an exception, using any state rights you have, or comparing cash-pay — which is often faster than appealing a fight you can’t win.
Exclusion vs. PA denial vs. formulary denial
- PA denial: the plan might cover it if you meet the rules. Fixable.
- Formulary denial: the drug needs an exception, or there’s a covered alternative.
- Exclusion: the plan says this benefit isn’t covered, period. This is the hard one.
FDA-approved doesn’t mean covered
A drug can be FDA-approved for weight management and still not be covered by your specific plan for that use. Approval and coverage are two different things — that surprises a lot of people, so don’t read an exclusion as a mistake.
A covered use may change the conversation — carefully, and only if it truly applies to you: Ozempic and Mounjaro may be covered for type 2 diabetes, Wegovy for heart-risk reduction in people with heart disease and obesity, Zepbound for sleep apnea in adults with obesity, and Wegovy for noncirrhotic MASH with moderate-to-advanced liver scarring.
When cash-pay is simply the rational move
If your plan excludes the drug, you can’t meet the criteria, or you can’t wait out an appeal, paying cash may beat the fight. Start with the maker’s own program — it’s usually the cheapest honest option.
| Program | Medication | Self-pay price (verified June 2, 2026) | Key limit | Source |
|---|---|---|---|---|
| NovoCare | Wegovy tablets | $149/mo for 1.5 mg and 4 mg (4 mg holds through Aug 31, 2026, then $199/mo) | Self-pay; varies by dose | NovoCare |
| NovoCare | Wegovy injection | $199/mo for first 2 fills 0.25–0.5 mg (through June 30, 2026), then $349/mo for 0.25–2.4 mg and $399/mo for Wegovy HD 7.2 mg | Self-pay | NovoCare |
| LillyDirect | Zepbound | $299/mo (2.5 mg), $399/mo (5 mg), $449/mo (7.5–15 mg when refilled within 45 days) | Self-pay; terms apply | LillyDirect |
| Manufacturer savings cards | Wegovy / Zepbound | As little as $25/mo for some eligible patients | Commercial insurance only — Medicare, Medicaid, and TRICARE excluded. Commercial insurance guide → | NovoCare / Zepbound |
For reference: list price without any program is around $1,349/month for Wegovy and $1,060/month for Zepbound — so these programs cut the cost dramatically. Confirm today’s prices on NovoCare.com and LillyDirect before you decide.
If you’d rather get the visit, the prescription, and the maker’s pricing coordinated in one place, FDA-approved telehealth platforms like Ro prescribe brand-name Wegovy and Zepbound and coordinate cash-pay pricing. You can compare options on our GLP-1 provider guide.
If it’s a true exclusion, compare your fallback paths →
Don’t sink weeks into a low-odds appeal when a faster path exists. Our free 60-second quiz shows whether an appeal, a different covered use, or transparent cash-pay makes the most sense for you. No account, no pressure.
When Does It Make Sense to Stop Appealing?
Stop appealing when the denial is a true exclusion, your deadline has passed, you can’t meet the plan’s rules, or a covered alternative is available and right for you. Stopping isn’t giving up — it’s picking the path that matches your coverage reality so you can actually start treatment.
Stop appealing if your letter says:
- “Weight-loss drugs are excluded”
- “This drug is not a covered benefit”
- “Plan does not cover anti-obesity medications”
- “Not covered for your diagnosis”
- “Excluded under employer benefit design”
Keep appealing if your letter says:
- “Missing records”
- “Insufficient documentation”
- “Step therapy not completed”
- “Medical necessity not established”
- “Continuation criteria not documented”
That first list is mostly a wall. The second list is mostly a door. Knowing the difference is the whole game.
If you want the insurance paperwork handled for you (advertiser)
Certain telehealth memberships include an insurance concierge that does the work for you. Ro Body’s insurance concierge checks your benefits, submits prior authorizations, resubmits for a different GLP-1 if one is denied, and helps navigate denials. Membership runs $39 for the first month, then as low as $74/month with an annual plan paid upfront, or $149/month ongoing (medication billed separately; insurance doesn’t cover the membership). GLP-1 options are FDA-approved brand names — Wegovy (pen and pill), the Zepbound KwikPen, Zepbound, Ozempic, Foundayo, and Saxenda. Last verified: June 2, 2026.
Honest note on government insurance:
Ro can’t coordinate insurance coverage for government plans. If you have Medicare, a Medicare supplement, or TRICARE, you may join and pay cash for certain options. If you have Medicaid or another government-funded plan, you can’t join or pay cash through Ro. FEHB members can join and use the insurance concierge. No service can overturn a true plan exclusion.
The RX Index may earn a commission if you start care through this link, at no extra cost to you.
How We Built This GLP-1 Appeal Levels Map
This guide was built from official appeal-rights resources, Medicare and CMS guidance, FDA approval updates, KFF coverage research, a state external-review example, and the providers’ own published policies. We used patient forums only for the language people use, not for medical, legal, or regulatory facts.
What we verified (as of ):
- HealthCare.gov internal-appeal and external-review timelines
- U.S. Department of Labor employer-plan appeal rights
- Medicare Part D’s five appeal levels and 2026 dollar thresholds ($200 and $1,960)
- CMS change moving the Part C/D appeal window from 60 to 65 days
- Medicare GLP-1 Bridge dates, drugs, $50 copay, and BMI-based eligibility
- FDA approval of Wegovy for cardiovascular risk reduction and noncirrhotic MASH
- FDA approval of Foundayo (orforglipron) for weight management
- KFF research on Medicare, Medicaid, and Marketplace coverage and appeals
- Current NovoCare and LillyDirect self-pay pricing
- Ro’s coverage checker, insurance concierge, and membership pricing
What still needs checking before you rely on it:
- Your exact deadline (read your denial letter)
- Your state’s Medicaid and external-review deadlines
- Today’s manufacturer and provider prices (they change monthly)
Frequently Asked Questions: GLP-1 Appeal Levels
These are the follow-up questions people search right after reading a denial letter. Use them as orientation — your plan documents and denial letter always control your exact deadline.
Is a prior authorization denial the same as Level 1?
Not quite. A denied prior authorization usually happens before or at the start of the formal appeal process. Once it is denied, your next step is typically a Level 1 internal appeal (private or employer plans) or a redetermination (Medicare).
What's the difference between an internal appeal and an external review?
An internal appeal asks the insurer to review its own decision again. An external review sends the dispute to an independent outside organization, and for most private plans that decision is binding on the insurer.
How long does a GLP-1 appeal take?
For private plans, HealthCare.gov lists about 30 days for internal appeals (care not yet received), 60 days (care already received), and 45 days for standard external review. Medicare drug appeals run about 7 days for standard decisions and 72 hours for fast appeals.
Can I appeal if my plan excludes weight-loss drugs?
You can usually ask for a review, but a true exclusion is much harder to overturn than a missing-document or medical-necessity denial. A better next step is often checking for a different covered use or comparing cash-pay options.
Should my doctor appeal, or should I?
Either may be allowed, depending on your plan. But GLP-1 appeals usually turn on your diagnosis, medical necessity, and what you have tried, so your prescriber's documentation is central.
Can I request a fast (expedited) appeal?
Possibly, but fast appeals are for medical urgency. Your prescriber usually needs to explain why waiting for the normal timeline could seriously harm your health.
What is an IRO?
An IRO is an Independent Review Organization — the outside group used in many external reviews. It looks at your denial separately from the insurer that made the original decision.
What is Medicare redetermination?
Redetermination is the first Medicare drug-appeal level, where your plan reviews its own denial. If it is denied again, the next level is reconsideration by an Independent Review Entity.
Can I keep taking my GLP-1 while I appeal?
It depends on your current supply, your plan's rules, any continuation benefits, and your prescriber's advice. Do not assume an appeal automatically keeps your medication coming.
Does Ro help with GLP-1 appeals?
Ro says its insurance concierge helps eligible commercial-insurance patients with prior authorizations and denial navigation, and its free coverage checker shows whether prior authorization is required. That is real help with the paperwork, but it is not a guarantee your appeal wins, and Ro cannot coordinate coverage for government insurance plans.
What if I missed the appeal deadline?
Call your plan right away and ask about late filing, good-cause exceptions, resubmitting, a fresh prior authorization, or another coverage path. The answer depends on your plan type, but do not assume it is over.
What if my employer changed GLP-1 coverage?
Ask HR for the plan document or the notice of changes, and find out whether it is a full exclusion, a new prior-authorization rule, a renewal rule, or a formulary change. Employer coverage is shifting quickly as plans react to GLP-1 costs.
Still not sure which GLP-1 program is right for you?
Free, no account, about a minute. It reads your situation and points you to the right next step — appeal, a covered alternative, or a cash-pay path to check next.
Get My GLP-1 Path →Related guides
Last updated: Last verified: The RX Index Editorial Team.
The RX Index is a pricing intelligence and comparison resource for GLP-1 telehealth providers. Some links on this page may be affiliate links; we may earn a commission at no extra cost to you if you start a program. Our recommendations are based on verified fit and accuracy, not payout.
This page is for general information only and is not medical, legal, or insurance advice. Your denial letter and plan documents set your real deadlines. Talk to a licensed clinician about whether a GLP-1 medication is right for you.